Physical activity as a negative modulator of estrogen-induced breast cancer

被引:0
|
作者
Yvonne M. Coyle
机构
[1] UT Southwestern Medical Center,Department of Internal Medicine, Hamon Center for Therapeutic Oncology Research
来源
Cancer Causes & Control | 2008年 / 19卷
关键词
Physical activity; Estrogen; Breast cancer;
D O I
暂无
中图分类号
学科分类号
摘要
Physical activity is a protective factor for breast cancer. Exposure to estrogen is an important determinant of breast cancer risk and exercise reduces estrogen levels, with the level of evidence being stronger for post-menopausal women. Possible mechanisms for estrogen induced breast cancer include increased breast epithelial cell proliferation, the metabolism of estrogen to genotoxic metabolites, such as DNA-adducts, and the silencing of tumor suppressor genes (TSGs) that have been implicated in breast carcinogenesis by inducing gene promoter hypermethylation, which is potentially reversible. Animal studies suggest that physical activity decreases breast tumor growth by promoting changes in cellular proliferation and apoptosis. Human studies provide some support for exercise producing favorable changes in estrogen metabolism that may lead to reduced breast epithelial cell proliferation. No studies have been performed to determine whether exercise decreases the accumulation of estrogen metabolite DNA-adducts in breast tissue. However, research supports the hypothesis that physical activity reduces promoter hypermethylation of TSGs implicated in breast carcinogenesis by lowering circulating estrogen levels. Thus, further research is necessary to clarify the mechanisms that relate to physical activity as a negative modulator of breast cancer risk to develop meaningful guidelines for the use of physical activity in breast cancer prevention.
引用
收藏
页码:1021 / 1029
页数:8
相关论文
共 50 条
  • [1] Physical activity as a negative modulator of estrogen-induced breast cancer
    Coyle, Yvonne M.
    CANCER CAUSES & CONTROL, 2008, 19 (10) : 1021 - 1029
  • [2] Sex steroid binding protein is a negative modulator of estrogen-induced breast cancer cell growth
    Frairia, R
    Fortunati, N
    Fazzari, A
    Fissore, F
    Comba, A
    Becchis, M
    Catalano, MG
    BenedusiPagliano, E
    Berta, L
    Mauro, M
    Gaidano, G
    BASIS FOR CANCER MANAGEMENT, 1996, 784 : 362 - 369
  • [3] Selective estrogen-induced apoptosis in breast cancer
    Obiorah, Ifeyinwa E.
    Fan, Ping
    Sengupta, Surojeet
    Jordan, V. Craig
    STEROIDS, 2014, 90 : 60 - 70
  • [4] ESTROGEN-INDUCED PROTEINS IN BREAST-CANCER
    VIGNON, F
    CAPONY, F
    GARCIA, M
    VEITH, F
    WESTLEY, B
    ROCHEFORT, H
    ANNALES D ENDOCRINOLOGIE, 1981, 42 (4-5) : 327 - 332
  • [5] ESTROGEN-INDUCED EXPANSION OF THE GROWTH FRACTION IN RECEPTOR NEGATIVE HUMAN-BREAST CANCER
    CONTE, PF
    FRASCHINI, G
    DREWINKO, B
    JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY, 1985, 23 (6B): : 1169 - 1172
  • [6] ESTROGEN-INDUCED EXPANSION OF THE GROWTH FRACTION IN RECEPTOR NEGATIVE HUMAN-BREAST CANCER
    CONTE, PF
    FRASCHINI, G
    DREWINKO, B
    JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY, 1983, 19 (02): : R10 - R10
  • [7] Estrogen-induced breast cancer in female ACI rats
    Li, SA
    Liao, JDZ
    Li, JJ
    HORMONAL CARCINOGENESIS III, 2001, : 178 - 188
  • [8] The Ah receptor inhibits estrogen-induced estrogen receptor β in breast cancer
    Kietz, S
    Thomsen, JS
    Matthews, J
    Pettersson, K
    Ström, A
    Gustafsson, JÅ
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2004, 320 (01) : 76 - 82
  • [9] Oxytocin: An estrogen-induced autocrine-paracrine modulator of bone cell activity
    Colucci, S
    Colaianni, G
    Tamma, R
    Di Benedetto, A
    Mori, G
    Camerino, C
    Grano, M
    Zallone, A
    BONE, 2004, 34 : S17 - S17
  • [10] Exploiting the mechanism of estrogen-induced transcription to fight breast cancer
    Perillo, Bruno
    Castoria, Gabriella
    Migliaccio, Antimo
    EXPERIMENTAL AND MOLECULAR MEDICINE, 2021, 53 (07): : 1205 - 1206